Search results for "Public health"
Transforming health care to improve U.S. life expectancy
The sobering decline in U.S. life expectancy reaffirms the exigency of health care reform anchored in a proactive and comprehensive approach.
https://immattersacp.org/archives/2023/10/transforming-health-care-to-improve-us-life-expectancy.htm
1 Oct 2023
Efforts to stop coprescribing of opioids, benzodiazepines helped, but problem ongoing
Two recent studies examined national trends in opioid and benzodiazepine prescribing, one finding that prescribing of these drugs together and separately dropped nationally, while another showing that opioid prescribing for patients with alcohol use disorder (AUD) decreased in New York.
https://immattersacp.org/weekly/archives/2022/06/07/4.htm
7 Jun 2022
Latest COVID-19 research details local vaccine reactions, ineffective outpatient treatments
A case series described delayed skin reactions to vaccination, and randomized trials indicated that ivermectin, azithromycin, and convalescent plasma didn't help mildly ill patients. Several studies focused on the increase in alcohol use during the pandemic.
https://immattersacp.org/weekly/archives/2021/03/09/1.htm
9 Mar 2021
Smoking cessation study supports ‘never too early, never too late’
Smoking cessation was consistently related to lower risk of coronary heart disease, stroke, and peripheral artery disease (PAD), although a significantly elevated risk for PAD persisted up to 30 years after smoking cessation.
https://immattersacp.org/weekly/archives/2019/07/23/4.htm
23 Jul 2019
Adults with subjective cognitive decline were more likely to report 4 modifiable risk factors for Alzheimer's disease
Among survey respondents ages 45 years and older, the most common modifiable risk factor for Alzheimer's disease and related dementias was hypertension (49.9%), followed by not meeting guidelines for aerobic physical activity (49.7%), obesity (35.3%), and diabetes (18.6%).
https://immattersacp.org/weekly/archives/2022/05/31/2.htm
31 May 2022
Fourth vaccine dose 62% effective against severe COVID-19 in month after receipt
Retrospective data from Israel showed that in people ages 60 years and older, an additional booster dose of the Pfizer-BioNTech COVID-19 vaccine was 55% effective against symptomatic disease and 68% effective against hospitalization.
https://immattersacp.org/weekly/archives/2022/04/19/4.htm
19 Apr 2022
ABIM Foundation seeks proposals for grants to challenge health misinformation
Two grants totaling $110,000 will be awarded to programs focused on improving quality of communication by providing accurate health information to the public, especially populations made vulnerable by misinformation.
https://immattersacp.org/weekly/archives/2022/01/18/6.htm
18 Jan 2022
Big barrier to buprenorphine removed
The U.S. government no longer requires an X waiver to treat patients with buprenorphine for opioid use disorder.
https://immattersacp.org/archives/2023/03/big-barrier-to-buprenorphine-removed.htm
1 Mar 2023
Register now for ACP and Annals of Internal Medicine's COVID-19 Forum VIII: Outpatient Evaluation and Management of Patients with COVID-19
During the Feb. 9 virtual live event, a panel of experts will discuss appropriate COVID-19 testing, quarantine and isolation periods, management of symptoms, and recommended treatments in the outpatient setting.
https://immattersacp.org/weekly/archives/2022/02/01/2.htm
1 Feb 2022
Fourth doses, stealth variant, rapid tests focus of latest COVID-19 research
A fourth vaccine dose increased antibodies but didn't significantly reduce infections in an Israeli study. Antibody response is similar with the stealth variant and with the original omicron variant, a small study showed. Other research found that a rapid antigen test caught most omicron infections, and the vaccines weren't associated with neurological conditions.
https://immattersacp.org/weekly/archives/2022/03/22/4.htm
22 Mar 2022